Skip to main content
Brainsway Ltd. logo

Brainsway Ltd. — Investor Relations & Filings

Ticker · BWAY ISIN · IL0011007189 TA Manufacturing
Open in API
Filings indexed 375 across all filing types
Latest filing 2020-01-14 Report Publication Anno…
Country IL Israel
Listing TA BWAY

About Brainsway Ltd.

https://www.brainsway.com/

Brainsway Ltd. is a medical technology company focused on developing and marketing advanced noninvasive neurostimulation treatments for mental health and addictive disorders. The company's core product is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) system, which uses a patented H-coil to stimulate deeper and broader regions of the brain. The technology is designed as a safe and effective non-drug treatment option. The Deep TMS system has received multiple FDA clearances for conditions including Major Depressive Disorder (MDD), anxious depression, and Obsessive-Compulsive Disorder (OCD), for which it was the first noninvasive medical device to receive such clearance. It is also FDA-cleared as an aid for short-term smoking cessation, the first TMS device to be cleared for an addiction indication.

Recent filings

Filing Released Lang Actions
Annual General Meeting results
Report Publication Announcement Classification · 1% confidence The document is a short filing (1749 chars) from BRAINSWAY LTD, reported via MAGNA to the Israel Securities Authority and Tel Aviv Stock Exchange on 14/01/2020. The key phrase is 'Attached hereto is a report on *GM results* *GM_Results_0120_isa.pdf*'. This structure—a brief announcement stating that a specific report (in this case, 'GM results') is attached—fits the definition of a Report Publication Announcement (RPA). It is not the full Annual Report (10-K) or an Interim Report (IR), but rather the notification of their release, adhering to the 'MENU VS MEAL' rule.
2020-01-14 English
Immediate Report of Meeting
AGM Information Classification · 1% confidence The document is titled 'Appendix A - Form of Statement of a Candidate to Serve as a Director' and explicitly references Israeli Companies Law requirements for director election. It details the qualifications, restrictions, and declarations required from a director candidate, noting that this statement will be presented at the 'Annual General Meeting of Shareholders of the Company in which my election shall be considered.' This material is directly related to the nomination and election process for the Board of Directors, which is a core component of Annual General Meeting (AGM) documentation. While it relates to management/directors, its specific function as a required statement for election makes it most closely aligned with AGM materials.
2019-12-09 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement Classification · 1% confidence The document is explicitly titled 'Proxy Card' and contains detailed instructions and a ballot for shareholders to vote on various resolutions concerning the appointment of auditors, re-election of directors, approval of compensation policies, and amendments to the Articles of Association for an upcoming 'Annual General Meeting' (AGM) scheduled for January 13, 2020. This material is designed to solicit shareholder votes prior to the meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it relates to the AGM, the document itself is the mechanism for voting, not the AGM presentation (AGM-R) or the results (DVA).
2019-12-09 English
Immediate Report of Meeting
AGM Information Classification · 1% confidence The document explicitly states it is a 'NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS' and a 'PROXY STATEMENT FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS'. It details the agenda items for the meeting (e.g., appointing auditors, electing directors, approving compensation) and provides instructions on how shareholders can vote via proxy. This content directly corresponds to the definition of materials related to an Annual General Meeting (AGM) and the solicitation of proxies, which maps to the 'AGM-R' (AGM Information) or 'PSI' (Proxy Solicitation & Information Statement) codes. Since the document is the full notice and proxy statement itself, and not just a brief announcement of its publication, AGM-R is the most appropriate primary classification, as it encompasses the entire AGM package, including the proxy solicitation details. The presence of the Form 6-K wrapper suggests this material is being filed with the SEC, but the core content is the AGM/Proxy material.
2019-12-09 English
Immediate Report of Meeting
AGM Information Classification · 1% confidence The document explicitly states it is a 'Notice of convening of meeting' for an 'annual meeting' scheduled for 13/01/2020. It details the agenda items, which include appointing auditors, re-electing directors, approving option grants, and approving compensation policies. This content is characteristic of materials related to an Annual General Meeting (AGM) and the associated voting process, which aligns directly with the AGM Information (AGM-R) or Proxy Solicitation & Information Statement (PSI) categories. Since the document is a formal notice detailing the agenda items that will be voted upon at the AGM, AGM-R is the most precise fit for the overall event notification, although PSI is also highly relevant for the voting materials. Given the context of announcing the meeting itself, AGM-R is selected.
2019-12-09 English
Immediate Report
Regulatory Filings Classification · 1% confidence The document is explicitly titled as a "FORM 6-K" filed with the SEC by a Foreign Private Issuer. Form 6-K is generally used to report material information that the company is required to disclose to its home country's regulators or stock exchange, or that it makes public in its home country. The content is a press release announcing the successful results of a pivotal multicenter study for smoking cessation and the intent to meet with the FDA. This type of announcement, which is material information released outside of the regular periodic reporting cycle (like 10-K or IR), is typically filed on Form 6-K. Since the provided filing categories do not have a specific code for 'Form 6-K', the most appropriate fallback category for a general, material regulatory announcement that doesn't fit the other specific types (like ER, CT, or DIV) is 'Regulatory Filings' (RNS). Although it contains detailed results, it is presented as a press release incorporated by reference into the 6-K, not a comprehensive quarterly or annual report.
2019-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.